|
Market Closed -
Other stock markets
|
After hours 16:15:15 | |||
| 140.91 USD | +6.73% |
|
123.30 | -12.50% |
| Market Cap | 8.49B 7.42B 6.85B 6.31B 11.9B 818B 12.16B 81.84B 32.19B 400B 31.89B 31.19B 1,379B | P/E 2026 * |
33.5x | P/E 2027 * | -115x |
|---|---|---|---|---|---|
| Enterprise Value | 7.92B 6.92B 6.38B 5.88B 11.09B 762B 11.34B 76.3B 30.01B 373B 29.73B 29.08B 1,285B | EV / Sales 2026 * |
15.5x | EV / Sales 2027 * | 48.7x |
| Free-Float |
97.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | +6.73% | ||
| 1 week | +7.22% | ||
| Current month | +14.95% | ||
| 1 month | +26.44% | ||
| 3 months | +32.96% | ||
| 6 months | +68.92% | ||
| Current year | +61.34% |
| 1 week | 125.32 |  | 141.08 |
| 1 month | 111.17 | | 141.1 |
| Current year | 77 | | 141.1 |
| 1 year | 50.48 | | 141.1 |
| 3 years | 13.72 | | 141.1 |
| 5 years | 6.91 | | 141.1 |
| 10 years | 4.47 | | 141.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 2008-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 2022-04-17 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 2026-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 2008-11-30 |
Harold Selick
CHM | Chairman | 71 | 2014-03-18 |
William Waddill
BRD | Director/Board Member | 69 | 2016-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/23/26 | Fiscal year | Director | 27,000 | 0.0420% | ||
| 6/10/26 | Fiscal year | Director | 27,000 | 0.0420% | ||
| 5/29/26 | Fiscal year | Director | 27,000 | 0.0420% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.73% | +7.22% | +149.66% | +567.50% | 8.49B | |
| -1.29% | -2.54% | -0.35% | +4.30% | 49.7B | |
| +3.90% | -0.39% | +376.72% | +599.59% | 38.09B | |
| -1.70% | +4.46% | +7.46% | +57.67% | 35.29B | |
| -2.01% | -0.76% | +26.35% | -6.83% | 35.13B | |
| +0.06% | +1.56% | +4.41% | +27.42% | 27.22B | |
| +0.46% | -3.49% | - | - | 16.14B | |
| -0.04% | -0.09% | +68.48% | +117.39% | 15.36B | |
| +1.12% | +2.15% | +16.24% | +19.12% | 13.89B | |
| 0.00% | +1.36% | +15.74% | -30.62% | 13.02B | |
| Average | +0.69% | -0.92% | +73.86% | +150.61% | 25.23B | |
| Weighted average by Cap. | +0.08% | -0.76% | +77.88% | +135.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 512M 447M 413M 380M 717M 49.27B 733M 4.93B 1.94B 24.13B 1.92B 1.88B 83.07B | 163M 142M 131M 121M 228M 15.67B 233M 1.57B 617M 7.67B 611M 598M 26.42B |
| Net income | 249M 217M 200M 185M 348M 23.94B 356M 2.4B 942M 11.72B 933M 913M 40.36B | -82.92M -72.46M -66.87M -61.63M -116M -7.99B -119M -799M -314M -3.91B -311M -305M -13.46B |
| Net Debt | -574M -502M -463M -427M -804M -55.27B -822M -5.53B -2.18B -27.07B -2.16B -2.11B -93.18B | -565M -494M -455M -420M -791M -54.38B -809M -5.44B -2.14B -26.64B -2.12B -2.07B -91.69B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | US$140.91 | +6.73% | 519,048 |
| 26-07-16 | US$132.02 | -2.54% | 602,064 |
| 26-07-15 | US$135.46 | +3.19% | 836,109 |
| 26-07-14 | US$131.27 | +1.06% | 564,974 |
| 26-07-13 | US$129.89 | -1.16% | 541,071 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
